Showing results (81-90 of 15,488) with videos related to
Sort By:
Pageof 1,549
International Immunopharmacology|December 17, 2022
Thymosin alpha1 use in adult COVID-19 patients: A systematic review and meta-analysis on clinical outcomesWeifeng Shang, Bo Zhang, Yali Ren, et al.International Immunopharmacology|December 17, 2022
Kaempferol modulates IFN-γ induced JAK-STAT signaling pathway and ameliorates imiquimod-induced psoriasis-like skin lesionsYanpeng Li, Haodong Cui, Shipeng Li, et al.International Immunopharmacology|January 12, 2023
C1q/tumor necrosis factor-related protein-6 exerts protective effects on myocardial ischemia-reperfusion injury through the modulation of the Akt-GSK-3β-Nrf2 signaling cascadeSumei Liang, Juanping Han, Weiping Cheng, et al.International Immunopharmacology|January 12, 2023
α-Cyperone protects dopaminergic neurons and inhibits neuroinflammation in LPS-induced Parkinson's disease rat model via activating Nrf2/HO-1 and suppressing NF-κB signaling pathwayBingxu Huang, Guiqiu Hu, Xiaofeng Zong, et al.International Immunopharmacology|January 15, 2023
Dimethyl fumarate ameliorates fungal keratitis by limiting fungal growth and inhibiting pyroptosisLingwen Gu, Jing Lin, Qian Wang, et al.International Immunopharmacology|January 17, 2023
A perspective on SARS-CoV-2 virus-like particles vaccinesXiaoyang Gao, Yeting Xia, Xiaofang Liu, et al.International Immunopharmacology|December 30, 2022
Taxifolin ameliorates cigarette smoke-induced chronic obstructive pulmonary disease via inhibiting inflammation and apoptosisXiangming Liu, Yiming Ma, Lijuan Luo, et al.International Immunopharmacology|December 30, 2022
Pneumocystis jiroveci Pneumonia secondary to tyrosine kinase inhibitor with blinatumomab therapy: A case reportXiaoning Wang, Hao Li, Jing Li, et al.International Immunopharmacology|December 31, 2022
Reverse vaccinology assisted design of a novel multi-epitope vaccine to target Wuchereria bancrofti cystatin: An immunoinformatics approachNabarun Chandra Das, Parth Sarthi Sen Gupta, Saroj Kumar Panda, et al.International Immunopharmacology|January 1, 2023
Advances in pharmacokinetics and pharmacodynamics of PD-1/PD-L1 inhibitorsTing Yan, Lun Yu, Dangang Shangguan, et al.Pageof 1,549